Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

被引：411
作者：
Montastruc, Jean-Louis [1 ,2 ]
Sommet, Agnes [1 ]
Bagheri, Haleh [1 ,2 ]
Lapeyre-Mestre, Maryse [1 ]
机构：
[1] Univ Toulouse, Fac Med, Lab Pharmacol Med & Clin, UMR INSERM U Equipe Pharmacoepidemiol 1027, F-31000 Toulouse, France
[2] Ctr Hosp Univ Toulouse, Ctr Midi Pyrenees Pharmaco Vigilance Pharmacoepid, Serv Pharmacol Clin, Toulouse, France
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 72卷 / 06期
关键词：
RISK;
D O I：
10.1111/j.1365-2125.2011.04037.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：905 / 908
页数：4
相关论文
共 10 条
[1]  
CHAVANT F, 2011, BR J CLIN PHARM, DOI DOI 10.1111/J.1365-2125.2011.04009.X
[2]   Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death [J].
De Bruin, ML ;
Pettersson, M ;
Meyboom, RHB ;
Hoes, AW ;
Leufkens, HGM .
EUROPEAN HEART JOURNAL, 2005, 26 (06) :590-597
[3]   Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database [J].
Montastruc, Guillaume ;
Favreliere, Sylvie ;
Sommet, Agnes ;
Pathak, Atul ;
Lapeyre-Mestre, Maryse ;
Perault-Pochat, Marie-Christine ;
Montastruc, Jean-Louis .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (03) :287-294
[4]   Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting [J].
Piccinni, Carlo ;
Motola, Domenico ;
Marchesini, Giulio ;
Poluzzi, Elisabetta .
DIABETES CARE, 2011, 34 (06) :1369-1371
[5]  
ROBERT E, 1983, LANCET, V2, P1142
[6]   The reporting odds ratio and its advantages over the proportional reporting ratio [J].
Rothman, KJ ;
Lanes, S ;
Sacks, ST .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (08) :519-523
[7]   A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system [J].
Schwan, Sofie ;
Sundstrom, Anders ;
Stjernberg, Elisabet ;
Hallberg, Ebba ;
Hallberg, Par .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (09) :947-953
[8]   Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004? [J].
Sommet, A. ;
Grolleau, S. ;
Bagheri, H. ;
Lapeyre-Mestre, M. ;
Montastruc, J. L. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (08) :829-834
[9]   Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs [J].
Souyri, C. ;
Olivier, P. ;
Grolleau, S. ;
Lapeyre-Mestre, M. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) :249-255
[10]   SERUM SICKNESS-LIKE REACTIONS TO CEFACLOR [J].
STRICKER, BHC ;
TIJSSEN, JGP .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (10) :1177-1184
1